New York, Feb 13, 2026, 13:59 (EST) — Regular session
- Moolec Science SA shares were up 85.6% at $9.47, with volume around 44.7 million shares
- The stock swung between $8.12 and $12.23 in the session
- The company reported commercial-scale results from its GLASO1 engineered safflower platform
Moolec Science SA shares jumped in afternoon trade on Friday, extending a sharp run that also brought repeated volatility pauses. The stock was up 85.6% at $9.47 as of 1:39 p.m. Eastern, after moving in a wide $8.12-$12.23 range on about 44.7 million shares of volume, MarketBeat data showed. (MarketBeat)
Moolec calls itself a science-based food ingredient company that engineers plants with animal protein genes, part of a broader push to make food inputs through “molecular farming.” For investors, the short test is whether new traits survive the messy handoff from field to mainstream processing. (Moolec Science)
That is why a single operations update can move this stock hard. In thin names, it does not take much — one press release, a rush of orders — and the tape starts to run.
Trading was paused five times for “volatility pause” halts on Friday, according to Cboe’s halt list, including a pause at 11:58 a.m. Eastern. The halts are part of the Limit Up-Limit Down mechanism, an automatic brake that pauses trading when prices move too quickly. (Cboe Global Markets)
Moolec said its 2025 U.S. GLASO1 safflower harvest was processed through standard U.S. crushing operations and confirmed gamma-linolenic acid concentrations of about 45%. The company said it planted 1,100 acres and averaged roughly 2,200 pounds per acre, up from about 1,400 pounds per acre in 2024. Chief executive Alejandro Antalich called it an “inflection point” and said the next job is converting the operating milestone into “sustainable, recurring revenue.” (Nasdaq)
The move comes against a backdrop of a recent reverse split. In a January filing, the company said it implemented a 15-for-1 share consolidation effective Jan. 5, cutting shares outstanding to 726,118 from about 10.9 million. (SEC)
But the rally does not settle the bigger question: can Moolec sell specialty oil at scale, at a price that sticks, and without fresh financing pressure. With repeated halts and a large intraday range, the downside is simple — the next quiet session, or a lack of follow-through, and the stock can give it back fast.
Investors are also watching the company’s Nasdaq compliance calendar. Nasdaq published in late January that a Hearings Panel granted Moolec continued listing subject to conditions, including a status update by the end of February and updated pro forma financial information by the end of March, with the panel retaining jurisdiction through May 13. (Nasdaq)
